0001209191-21-048255.txt : 20210726
0001209191-21-048255.hdr.sgml : 20210726
20210726202921
ACCESSION NUMBER: 0001209191-21-048255
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210723
FILED AS OF DATE: 20210726
DATE AS OF CHANGE: 20210726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collins Cynthia
CENTRAL INDEX KEY: 0001405692
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39376
FILM NUMBER: 211115629
MAIL ADDRESS:
STREET 1: 65 WEST WATKINS MILL ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Poseida Therapeutics, Inc.
CENTRAL INDEX KEY: 0001661460
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 472846548
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-779-3100
MAIL ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-23
0
0001661460
Poseida Therapeutics, Inc.
PSTX
0001405692
Collins Cynthia
C/O POSEIDA THERAPEUTICS, INC.
9390 TOWNE CENTRE DRIVE, SUITE 200
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
8.63
2021-07-23
4
A
0
87440
0.00
A
2031-07-23
Common Stock
87440
87440
D
The stock option will vest and become exercisable in 36 equal monthly installments following the grant date set forth in column 3 above.
/s/ Harry J. Leonhardt, Attorney-in-Fact
2021-07-26